Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.02 (+0.20%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMII) Payables (2024 - 2025)

Drugs Made In America Acquisition (DMII) posted quarterly Payables of $99359.0 for Q4 2025, down 60.27% year-over-year from $250100.0 in Q4 2024, and up 2063.74% quarter-over-quarter from $4592.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Payables (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Payables for 2 consecutive years, with $99359.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Payables fell 60.27% year-over-year to $99359.0; the TTM figure through Dec 2025 stood at $99359.0 (down 60.27% YoY), while the FY2025 annual figure was $99359.0, down 60.27% from the prior year.
  • Payables advanced to $99359.0 in Q4 2025 per DMII's latest filing, from $4592.0 in the prior quarter.
  • Across five years, Payables topped out at $250100.0 in Q4 2024 and bottomed at $4592.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 58,428.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - 462,253.00
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 25,000.00
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 595,000.00
6 Aldel Financial 397.49 Mn 397.49 Mn - 20,057.00
7 Pioneer Acquisition I 390.89 Mn 653.32 Mn - -
8 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 38,850.00
9 Gores Holdings X 385.06 Mn 384.87 Mn - -1.52 Mn
10 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 8.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 99,359.00
Sep 30, 2025 4,592.00
Dec 31, 2024 250,100.00